Literature DB >> 26392499

Effect of Preexposure to Triazoles on Susceptibility and Virulence of Rhizopus oryzae.

Anne-Pauline Bellanger1, Nathaniel D Albert2, Russell E Lewis3, Thomas J Walsh4, Dimitrios P Kontoyiannis5.   

Abstract

Triazole prophylaxis has become the norm in patients with hematological malignancies. Breakthrough infections caused by Mucorales during triazole prophylaxis remain a challenging problem. We found that preexposure of Rhizopus oryzae to antifungal triazoles (fluconazole, voriconazole, posaconazole, and itraconazole) did not modify the in vitro susceptibility of Rhizopus oryzae to posaconazole. In contrast, preexposure of Rhizopus to triazoles was associated with the enhanced in vitro susceptibility of R. oryzae to amphotericin B. Preexposure to posaconazole did not alter the virulence of R. oryzae in the fly model of mucormycosis.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26392499      PMCID： PMC4649224          DOI： 10.1128/AAC.01583-15

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  18 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Itraconazole-amphotericin B antagonism in Aspergillus fumigatus: an E-test-based strategy.

Authors:  D P Kontoyiannis; R E Lewis; N Sagar; G May; R A Prince; K V Rolston
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey.

Authors:  Livio Pagano; Luisa Verga; Alessandro Busca; Bruno Martino; Maria Enza Mitra; Rosa Fanci; Stelvio Ballanti; Marco Picardi; Carlo Castagnola; Chiara Cattaneo; Gianpaolo Nadali; Annamaria Nosari; Anna Candoni; Morena Caira; Prassede Salutari; Federica Lessi; Franco Aversa; Mario Tumbarello
Journal:  J Antimicrob Chemother       Date:  2014-06-19       Impact factor: 5.790

4.  Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.

Authors:  Dimitrios P Kontoyiannis; Michail S Lionakis; Russell E Lewis; Georgios Chamilos; Mimi Healy; Cheryl Perego; Amar Safdar; Hagop Kantarjian; Richard Champlin; Thomas J Walsh; Issam I Raad
Journal:  J Infect Dis       Date:  2005-03-16       Impact factor: 5.226

5.  Itraconazole preexposure attenuates the efficacy of subsequent amphotericin B therapy in a murine model of acute invasive pulmonary aspergillosis.

Authors:  Russell E Lewis; Randall A Prince; Jingduan Chi; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

6.  Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.

Authors:  Gregory A Lamaris; Ronen Ben-Ami; Russell E Lewis; Georgios Chamilos; George Samonis; Dimitrios P Kontoyiannis
Journal:  J Infect Dis       Date:  2009-05-01       Impact factor: 5.226

7.  Drosophila melanogaster as a model host to dissect the immunopathogenesis of zygomycosis.

Authors:  Georgios Chamilos; Russell E Lewis; Jianhua Hu; Lianchun Xiao; Tomasz Zal; Michel Gilliet; Georg Halder; Dimitrios P Kontoyiannis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-26       Impact factor: 11.205

8.  Does pre-exposure of Aspergillus fumigatus to voriconazole or posaconazole in vitro affect its virulence and the in vivo activity of subsequent posaconazole or voriconazole, respectively? A study in a fly model of aspergillosis.

Authors:  G A Lamaris; R Ben-Ami; R E Lewis; D P Kontoyiannis
Journal:  J Antimicrob Chemother       Date:  2008-06-10       Impact factor: 5.790

9.  Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.

Authors:  Livio Pagano; Morena Caira; Anna Candoni; Franco Aversa; Carlo Castagnola; Cecilia Caramatti; Chiara Cattaneo; Mario Delia; Maria Rosaria De Paolis; Roberta Di Blasi; Luigi Di Caprio; Rosa Fanci; Mariagrazia Garzia; Bruno Martino; Lorella Melillo; Maria Enza Mitra; Gianpaolo Nadali; Annamaria Nosari; Marco Picardi; Leonardo Potenza; Prassede Salutari; Enrico Maria Trecarichi; Mario Tumbarello; Luisa Verga; Nicola Vianelli; Alessandro Busca
Journal:  Clin Infect Dis       Date:  2012-09-05       Impact factor: 9.079

10.  Fatal Breakthrough Mucormycosis in an Acute Myelogenous Leukemia Patient while on Posaconazole Prophylaxis.

Authors:  Seung Hun Kang; Hyun Seon Kim; Myoung Nam Bae; Jihye Kim; Ji Yeon Yoo; Kwan Yong Lee; Dong-Gun Lee; Hee-Je Kim
Journal:  Infect Chemother       Date:  2015-03-30
View more
  4 in total

1.  Preexposure to Isavuconazole Increases the Virulence of Mucorales but Not Aspergillus fumigatus in a Drosophila melanogaster Infection Model.

Authors:  Sebastian Wurster; Russell E Lewis; Nathaniel D Albert; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

2.  Functional Genomic and Biochemical Analysis Reveals Pleiotropic Effect of Congo Red on Aspergillus fumigatus.

Authors:  Zhonghua Liu; Shriya Raj; Norman van Rhijn; Marcin Fraczek; Jean-Philippe Michel; Odile Sismeiro; Rachel Legendre; Hugo Varet; Thierry Fontaine; Michael Bromley; Jean-Paul Latgé
Journal:  mBio       Date:  2021-05-18       Impact factor: 7.867

3.  ERG11 Gene Mutations and MDR1 Upregulation Confer Pan-Azole Resistance in Candida tropicalis Causing Disseminated Candidiasis in an Acute Lymphoblastic Leukemia Patient on Posaconazole Prophylaxis.

Authors:  Liangshun You; Wenbin Qian; Qing Yang; Liping Mao; Li Zhu; Xianbo Huang; Jie Jin; Haitao Meng
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

Review 4.  Therapy of Mucormycosis.

Authors:  Nikolaos V Sipsas; Maria N Gamaletsou; Amalia Anastasopoulou; Dimitrios P Kontoyiannis
Journal:  J Fungi (Basel)       Date:  2018-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.